When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
In 2019, the art of fixing the troublesome gene mutations known to cause severe, life-threatening illnesses took some big steps forward. That helped investors who began 2019 with shares of Crispr Therapeutics(NASDAQ: CRSP) and Editas Medicine(NASDAQ: EDIT), two gene-editing pioneers, record some market-beating gains.
Which one has the best chance to beat the market again in 2020 and beyond? When it comes to gene-editing stocks, there are a lot of ins and outs to consider. Let's lay the most important ones side by side to see which is the better buy right now.